OMN6

DRUG2 trials

Sponsors

Omnix Medical Ltd., Omnix Medical Ltd

Conditions

Hospital-acquired Bacterial PneumoniaHospital-acquired bacterial pneumonia or ventilated-associated bacterial pneumonia caused by Acinetobacter baumannii complex.Ventilator-associated Bacterial Pneumonia

Phase 2

A Clinical Trial to Assess the Safety and PK of OMN6 in HABP or VABP Caused by Acinetobacter Baumannii Complex

RecruitingNCT06087536

Omnix Medical LtdHospital-acquired Bacterial Pneumonia, Ventilator-associated Bacterial Pneumonia

Start: 2026-05-14End: 2027-03-01Target: 54Updated: 2026-07-02

A prospective, multinational, multicenter, randomized, sequential, double-blind, placebo-controlled, phase 2a clinical study to assess the safety and pharmacokinetics (PK) of OMN6 in hospital-acquired bacterial pneumonia (HABP) or ventilated-associated bacterial pneumonia (VABP) caused by Acinetobacter baumannii complex (ABC).

Not yet recruitingCTIS2025-524200-29-00

Omnix Medical Ltd.Hospital-acquired bacterial pneumonia or ventilated-associated bacterial pneumonia caused by Acinetobacter baumannii complex.

Target: 24Updated: 2026-05-07